» Articles » PMID: 10623691

Is Radiation Therapy a Preferred Alternative to Surgery for Squamous Cell Carcinoma of the Base of Tongue?

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2000 Jan 7
PMID 10623691
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate irradiation alone for treatment of base-of-tongue cancer.

Patients And Methods: Two hundred seventeen patients with squamous cell carcinoma of the base of tongue were treated with radiation alone and had follow-up for >/= 2 years.

Results: Local control rates at 5 years were as follows: T1, 96%; T2, 91%; T3, 81%; and T4, 38%. Multivariate analysis revealed that T stage (P =.0001) and overall treatment time (P =.0006) significantly influenced local control. The 5-year rates of local-regional control were as follows: I, 100%; II, 100%; III, 83%; IVA, 64%; and IVB, 65%. Multivariate analysis revealed that the following parameters significantly affect the probability of this end point: T stage (P =.0001), overall treatment time (P =.0001), overall stage (P =.0131), and addition of a neck dissection (P =.0021). The rates of absolute and cause-specific survival at 5 years were as follows: I, 50% and 100%; II, 81% and 100%; III, 65% and 76%; IVA, 42% and 56%; and IVB, 44% and 52%. Severe radiation complications developed in eight patients (4%).

Conclusion: The likelihood of cure after external-beam irradiation was related to stage, overall treatment time, and addition of a planned neck dissection. The local-regional control rates and survival rates after radiation therapy were comparable to those after surgery, and the morbidity associated with irradiation was less.

Citing Articles

Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects.

Embring A, Onjukka E, Mercke C, Lax I, Berglund A, Friesland S Cancers (Basel). 2023; 15(9).

PMID: 37174046 PMC: 10177133. DOI: 10.3390/cancers15092580.


Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost.

Embring A, Onjukka E, Mercke C, Lax I, Berglund A, Friesland S Radiat Oncol. 2023; 18(1):65.

PMID: 37029424 PMC: 10082532. DOI: 10.1186/s13014-023-02256-x.


Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.

Park S, Cho Y, Lee J, Koh Y, Kim S, Choi E Cancer Res Treat. 2017; 50(4):1214-1225.

PMID: 29281874 PMC: 6192900. DOI: 10.4143/crt.2017.498.


Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long-term results from a uniform clinical series.

Johansson B, Karlsson L, Reizenstein J, Von Beckerath M, Hardell L, Persliden J J Contemp Brachytherapy. 2016; 3(1):11-17.

PMID: 27877195 PMC: 5108831. DOI: 10.5114/jcb.2011.21037.


Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey.

Gorphe P, Blanchard P, Moriniere S, Fakhry N Eur Arch Otorhinolaryngol. 2015; 273(8):2201-7.

PMID: 26253428 DOI: 10.1007/s00405-015-3744-0.